Potential role of type 5 phosphodiesterase inhibition in the treatment of congestive heart failure.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 12556672)

Published in Congest Heart Fail on January 30, 2003

Authors

S D Katz1

Author Affiliations

1: Yale University School of Medicine, Heart Failure Center, Yale University, 135 College Street, Suite 201, New Haven, CT 06510, USA. stuart.katz@yale.edu